Endobiliary and Pancreatic Radiofrequency Ablations

Abstract

Radio frequency ablation (RFA) involves use of thermal energy to perform ablation of tissues. It has a wide range of application in gastrointestinal tract. Over the last few years, several studies have reported successful and safe application in the biliary and pancreatic tissues. It is particularly beneficial in patients with biliary malignancies in whom it has shown to improve survival. Additionally, it can be applied in occluded metal stents secondary to tumor ingrowth to prolong the patency of stents. In pancreas, RFA can successfully ablate cystic lesions and neuroendocrine tumors. It has also been applied in unresectable pancreatic cancers. This review discusses the application of endobiliary and pancreatic RFAs.

Keywords

biliary cancer - biliary RFA - pancreatic cystic neoplasm - pancreatic neuroendocrine tumor - pancreatic RFA

Grant Support

Midas Medical Foundation, Nagpur, India.

Publikationsverlauf

Artikel online veröffentlicht:
23. Dezember 2022

• References

• 1 Cho JH, Lee KH, Kim JM, Kim YS, Lee DH, Jeong S. Safety and effectiveness of endobiliary radiofrequency ablation according to the different power and target temperature in a swine model. J Gastroenterol Hepatol 2017; 32 (02) 521-526
• 2 Larghi A, Rimbaş M, Tringali A, Boškoski I, Rizzatti G, Costamagna G. Endoscopic radiofrequency biliary ablation treatment: a comprehensive review. Dig Endosc 2019; 31 (03) 245-255
• 3 Barret M, Leblanc S, Vienne A. et al. Optimization of the generator settings for endobiliary radiofrequency ablation. World J Gastrointest Endosc 2015; 7 (16) 1222-1229
• 4 Inoue T, Ibusuki M, Kitano R. et al. Endobiliary radiofrequency ablation combined with bilateral metal stent placement for malignant hilar biliary obstruction. Endoscopy 2020; 52 (07) 595-599
• 5 Cui W, Fan W, Lu M. et al. Percutaneous intraductal radiofrequency ablation for malignant biliary obstruction caused by recurrence and metastasis after primary tumor resection. Oncol Res Treat 2018; 41 (1-2): 22-28
• 6 Kong YL, Zhang HY, Liu CL. et al. Improving biliary stent patency for malignant obstructive jaundice using endobiliary radiofrequency ablation: experience in 150 patients. Surg Endosc 2022; 36 (03) 1789-1798
• 7 Sofi AA, Khan MA, Das A. et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc 2018; 87 (04) 944-951.e1
• 8 Kallis Y, Phillips N, Steel A. et al. Analysis of endoscopic radiofrequency ablation of biliary malignant strictures in pancreatic cancer suggests potential survival benefit. Dig Dis Sci 2015; 60 (11) 3449-3455
• 9 Wadsworth CA, Westaby D, Khan SA. Endoscopic radiofrequency ablation for cholangiocarcinoma. Curr Opin Gastroenterol 2013; 29 (03) 305-311
• 10 Laleman W, van der Merwe S, Verbeke L. et al. A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: the IGNITE-1 study. Endoscopy 2017; 49 (10) 977-982
• 11 Akinci D, Unal E, Ciftci TT, Kyendyebai S, Abbasoglu O, Akhan O. Endobiliary radiofrequency ablation in the percutaneous management of refractory benign bilioenteric anastomosis strictures. AJR Am J Roentgenol 2019; 212 (03) W83-W91
• 12 Inoue T, Ibusuki M, Kitano R. et al. Endoscopic ultrasound-guided antegrade radiofrequency ablation and metal stenting with hepaticoenterostomy for malignant biliary obstruction: a prospective preliminary study. Clin Transl Gastroenterol 2020; 11 (10) e00250
• 13 Rossi S, Viera FT, Ghittoni G. et al. Radiofrequency ablation of pancreatic neuroendocrine tumors: a pilot study of feasibility, efficacy, and safety. Pancreas 2014; 43 (06) 938-945
• 14 Gaidhane M, Smith I, Ellen K. et al. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) of the pancreas in a porcine model. Gastroenterol Res Pract 2012; 2012: 431451
• 15 Song TJ, Seo DW, Lakhtakia S. et al. Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc 2016; 83 (02) 440-443
• 16 Barthet M, Giovannini M, Lesavre N. et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study. Endoscopy 2019; 51 (09) 836-842
• 17 Imperatore N, de Nucci G, Mandelli ED. et al. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a systematic review of the literature. Endosc Int Open 2020; 8 (12) E1759-E1764
• 18 Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362 (17) 1605-1617
• 19 Cantore M, Girelli R, Mambrini A. et al. Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma. Br J Surg 2012; 99 (08) 1083-1088
• 20 Haen SP, Pereira PL, Salih HR, Rammensee HG, Gouttefangeas C. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol 2011; 2011: 160250
• 21 Bang JY, Sutton B, Hawes RH, Varadarajulu S. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos). Gastrointest Endosc 2019; 89 (01) 58-66.e3
• 22 Navaneethan U, Thosani N, Goodman A. et al; ASGE Technology Committee. Radiofrequency ablation devices. VideoGIE 2017; 2 (10) 252-259
• 23 Sharaiha RZ, Natov N, Glockenberg KS, Widmer J, Gaidhane M, Kahaleh M. Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit?. Dig Dis Sci 2014; 59 (12) 3099-3102
• 24 Hu B, Gao DJ, Zhang X, Zhang YC. Endobiliary radiofrequency ablation improve overall survival of cholangiocarcinoma: a multi-center randomized control study. Gastrointest Endosc 2016; 83 (05) AB126
• 25 Wang J, Zhao L, Zhou C. et al. Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for nonresectable malignant biliary obstruction improves stent patency but not survival. Medicine (Baltimore) 2016; 95 (15) e3329
• 26 Dutta AK, Basavaraju U, Sales L, Leeds JS. Radiofrequency ablation for management of malignant biliary obstruction: a single-center experience and review of the literature. Expert Rev Gastroenterol Hepatol 2017; 11 (08) 779-784
• 27 Yang J, Wang J, Zhou H. et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial. Endoscopy 2018; 50 (08) 751-760
• 28 Bokemeyer A, Matern P, Bettenworth D. et al. Endoscopic radiofrequency ablation prolongs survival of patients with unresectable hilar cholangiocellular carcinoma - a case-control study. Sci Rep 2019; 9 (01) 13685
• 29 Kang H, Chung MJ, Cho IR. et al. Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL. Surg Endosc 2021; 35 (01) 63-73
• 30 Gao DJ, Yang JF, Ma SR. et al. Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial. Gastrointest Endosc 2021; 94 (01) 91-100.e2
• 31 Armellini E, Crinò SF, Ballarè M, Occhipinti P. Endoscopic ultrasound-guided radiofrequency ablation of a pancreatic neuroendocrine tumor. Endoscopy 2015; 47 (1, Suppl 1 UCTN) E600-E601
• 32 Pai M, Habib N, Senturk H. et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg 2015; 7 (04) 52-59
• 33 Lakhtakia S, Ramchandani M, Galasso D. et al. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos). Gastrointest Endosc 2016; 83 (01) 234-239
• 34 Waung JA, Todd JF, Keane MG, Pereira SP. Successful management of a sporadic pancreatic insulinoma by endoscopic ultrasound-guided radiofrequency ablation. Endoscopy 2016; 48 (Suppl. 01) E144-E145
• 35 Bas-Cutrina F, Bargalló D, Gornals JB. Small pancreatic insulinoma: successful endoscopic ultrasound-guided radiofrequency ablation in a single session using a 22-G fine needle. Dig Endosc 2017; 29 (05) 636-638
• 36 Choi JH, Seo DW, Song TJ. et al. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors. Endoscopy 2018; 50 (11) 1099-1104
• 37 Thosani N, Sharma NR, Raijman I. et al. Safety and efficacy of endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) in the treatment of pancreatic lesions: a multi-center experience. Gastrointest Endosc 2018; 87 (06) AB84
• 38 Lamine F, Godat S, Marino L. et al. A Case of Benign Insulinoma Successfully Treated with Endoscopic Ultrasound Guided Radiofrequency Ablation. Bioscientifica; 2018
• 39 Oleinikov K, Dancour A, Epshtein J. et al. Endoscopic ultrasound-guided radiofrequency ablation: a new therapeutic approach for pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 2019; 104 (07) 2637-2647
• 40 de Nucci G, Imperatore N, Mandelli ED, di Nuovo F, d'Urbano C, Manes G. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series. Endosc Int Open 2020; 8 (12) E1754-E1758
• 41 Matsui Y, Nakagawa A, Kamiyama Y, Yamamoto K, Kubo N, Nakase Y. Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas 2000; 20 (01) 14-20
• 42 Wu Y, Tang Z, Fang H. et al. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol 2006; 94 (05) 392-395
• 43 Spiliotis JD, Datsis AC, Michalopoulos NV. et al. Radiofrequency ablation combined with palliative surgery may prolong survival of patients with advanced cancer of the pancreas. Langenbecks Arch Surg 2007; 392 (01) 55-60
• 44 Girelli R, Frigerio I, Salvia R, Barbi E, Tinazzi Martini P, Bassi C. Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer. Br J Surg 2010; 97 (02) 220-225
• 45 Singh V, Varshney S, Sewkani A. et al. Radiofrequency ablation of unresectable pancreatic carcinoma: 10-year experience from single centre. Pancreatology 2011; 11 (Suppl. 01) 52
• 46 Hadjicostas P, Malakounides N, Varianos C, Kitiris E, Lerni F, Symeonides P. Radiofrequency ablation in pancreatic cancer. HPB (Oxford) 2006; 8 (01) 61-64
• 47 Varshney S, Sewkani A, Sharma S. et al. Radiofrequency ablation of unresectable pancreatic carcinoma: feasibility, efficacy and safety. JOP 2006; 7 (01) 74-78
• 48 Casadei R, Ricci C, Pezzilli R. et al. A prospective study on radiofrequency ablation locally advanced pancreatic cancer. Hepatobiliary Pancreat Dis Int 2010; 9 (03) 306-311
• 49 Zou YP, Li WM, Zheng F. et al. Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer. World J Gastroenterol 2010; 16 (40) 5104-5110
• 50 Ikuta S, Kurimoto A, Iida H. et al. Optimal combination of radiofrequency ablation with chemoradiotherapy for locally advanced pancreatic cancer. World J Clin Oncol 2012; 3 (01) 12-14
• 51 Date RS, Siriwardena AK. Radiofrequency ablation of the pancreas. II: intra-operative ablation of non-resectable pancreatic cancer. A description of technique and initial outcome. JOP 2005; 6 (06) 588-592